Signal
Swiss Healthtech Hilo Secures $19 Million to Scale Cuffless Blood Pressure Monitoring
Summary
Aktiia's Hilo brand has extended its Series B to $119 million total, backed by the Dell Family Office. This capital injection accelerates the commercialization of wrist-worn optical sensor technology designed to replace the standard inflatable cuff for continuous hypertension management.
The company works in Cardiovascular and Devices, and this round at Series B ($19M) is new money into that part of the market. Compare it with other recent rounds to see whether prices here are rising or holding steady.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- OVUM Primary source
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.